Friends! In this video, I will analyze ZETA stock and discuss the risks and upside potential of ZETA
1 extracted signal · 1 resolved · 0 still active
The Patient Investor24 Oct 2025, 22:21 UTC
AI-generated source summary
This video analyzes Zeta Global Holdings Corp (ZETA), focusing on its potential as an AI stock. The speaker notes the company has a consistent growth with 28% CAGR since 2021, with revenue growth accelerating and a large base of 245 million individuals. The company is shifting EPS from negative to positive.The speaker claims based on the financial information and the long term customer base of ZETA stock, that ZETA sales multiple of about 3x, should be between 5x to 7x revenues resulting in a 99% upside if the markets adjust it sales level to the financial strength of the company. The target price is inferred as a doubled current price to 37.38 to reflect such growth, the failure bound set around 15 to invalidate the analysis.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
